Concepedia

Publication | Closed Access

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.

201

Citations

11

References

2001

Year

Larry W. Moreland, S. Cohen, Scott W. Baumgartner, Elizabeth A. Tindall, Ken J. Bulpitt, Richard W. Martin, Michael E. Weinblatt, James Taborn, A. Weaver, Daniel Burge,
PubMed

Abstract

Etanercept continued to be safe and well tolerated, and its clinical benefit was sustained for a median of 25 mo and for as long as 43 mo in patients with RA.

References

YearCitations

Page 1